Literature DB >> 16728708

IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.

Cassandra L Mikols1, Le Yan, Jin Y Norris, Tonya D Russell, Anthony P Khalifah, Ramsey R Hachem, Murali M Chakinala, Roger D Yusen, Mario Castro, Elbert Kuo, G Alexander Patterson, Thalachallour Mohanakumar, Elbert P Trulock, Michael J Walter.   

Abstract

RATIONALE: Bronchiolitis obliterans syndrome is the leading cause of chronic lung allograft dysfunction. We have demonstrated that respiratory viral infection is a bronchiolitis obliterans syndrome risk factor and virus-dependent injury induces expression of innate airway epithelial genes belonging to the interleukin (IL)-12 family. Thus, we hypothesized that epithelial cell IL-12 family members could mediate lung allograft dysfunction.
OBJECTIVES: We used mouse and human allograft specimens to evaluate the role of epithelial cell IL-12 family members in allograft dysfunction associated with and without viral infection.
METHODS: Murine and human IL-12 family members were characterized and manipulated in allografts and then correlated with epithelial cell injury, immune cell accumulation, and collagen deposition.
RESULTS: In a mouse model of lung transplantation, concurrent viral infection and allogeneic transplantation increased epithelial injury and this was followed by exaggerated accumulation of macrophages and collagen deposition. This virus-driven allograft dysfunction was associated with an epithelial innate response manifested by a synergistic increase in the production of the macrophage chemoattractant IL-12 p80 (p80), but not IL-12 or IL-23. Blockade or overexpression of donor epithelial p80 resulted in a corresponding abrogation or enhancement of macrophage accumulation and allograft dysfunction. We extended these findings to human recipients with viral infection and transplant bronchitis and again observed excessive epithelial p80 expression that correlated with increased macrophage accumulation.
CONCLUSIONS: These experiments support a role for an enhanced epithelial innate response as a central process in allograft dysfunction and identify the macrophage chemoattractant p80 as an innate epithelial effector of disease progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728708      PMCID: PMC2648123          DOI: 10.1164/rccm.200512-1886OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  52 in total

1.  Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  H Nakamura; K Komatsu; M Ayaki; S Kawamoto; M Murakami; N Uoshima; T Yagi; T Hasegawa; M Yasumi; T Karasuno; H Teshima; A Hiraoka; T Masaoka
Journal:  J Allergy Clin Immunol       Date:  2000-07       Impact factor: 10.793

2.  Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group.

Authors:  A Elssner; F Jaumann; S Dobmann; J Behr; M Schwaiblmair; H Reichenspurner; H Fürst; J Briegel; C Vogelmeier
Journal:  Transplantation       Date:  2000-07-27       Impact factor: 4.939

3.  Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients.

Authors:  M Sykes; D A Pearson; P A Taylor; G L Szot; S J Goldman; B R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  1999       Impact factor: 5.742

4.  Early lung leukocyte infiltration, HLA and adhesion molecule expression predict chronic rejection.

Authors:  G Devouassoux; C Pison; C Drouet; I Pin; C Brambilla; E Brambilla
Journal:  Transpl Immunol       Date:  2001-02       Impact factor: 1.708

5.  Expression of MHC antigens in normal human lungs and transplanted lungs with obliterative bronchiolitis.

Authors:  P M Taylor; M L Rose; M H Yacoub
Journal:  Transplantation       Date:  1989-09       Impact factor: 4.939

6.  Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase.

Authors:  E Gabbay; E H Walters; B Orsida; H Whitford; C Ward; T C Kotsimbos; G I Snell; T J Williams
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

7.  Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens.

Authors:  Xiang Xu; Jeffrey A Golden; Gregory Dolganov; Kirk D Jones; Samantha Donnelly; Timothy Weaver; George H Caughey
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

8.  IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1.

Authors:  Tonya D Russell; Qingyun Yan; Guangshun Fan; Anthony P Khalifah; D Keith Bishop; Steven L Brody; Michael J Walter
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.

Authors:  Anthony P Khalifah; Ramsey R Hachem; Murali M Chakinala; Kenneth B Schechtman; G Alexander Patterson; Daniel P Schuster; Thalachallour Mohanakumar; Elbert P Trulock; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2004-05-06       Impact factor: 21.405

10.  Interleukin 12 p40 production by barrier epithelial cells during airway inflammation.

Authors:  M J Walter; N Kajiwara; P Karanja; M Castro; M J Holtzman
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  16 in total

Review 1.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

2.  Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.

Authors:  Raksha Jain; Ramsey R Hachem; Matthew R Morrell; Elbert P Trulock; Murali M Chakinala; Roger D Yusen; Howard J Huang; Thalachallour Mohanakumar; G Alexander Patterson; Michael J Walter
Journal:  J Heart Lung Transplant       Date:  2010-02-04       Impact factor: 10.247

3.  Inhibition of secretion of interleukin (IL)-12/IL-23 family cytokines by 4-trifluoromethyl-celecoxib is coupled to degradation via the endoplasmic reticulum stress protein HERP.

Authors:  Martin McLaughlin; Iraide Alloza; Hung Pham Quoc; Christopher J Scott; Yasuhiko Hirabayashi; Koen Vandenbroeck
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

4.  IL-12 p80-dependent macrophage recruitment primes the host for increased survival following a lethal respiratory viral infection.

Authors:  Sean Gunsten; Cassandra L Mikols; Mitchell H Grayson; Reto A Schwendener; Eugene Agapov; Rose M Tidwell; Carolyn L Cannon; Steven L Brody; Michael J Walter
Journal:  Immunology       Date:  2008-09-06       Impact factor: 7.397

5.  IL-12p40 Homodimer Ameliorates Experimental Autoimmune Arthritis.

Authors:  Seon-Yeong Lee; Young Ok Jung; Doo-Jin Kim; Chang-Min Kang; Young-Mee Moon; Yu-Jung Heo; Hye-Jwa Oh; Seong-Jeong Park; Se-Hwan Yang; Seung Ki Kwok; Ji-Hyeon Ju; Sung-Hwan Park; Young Chul Sung; Ho-Youn Kim; Mi-La Cho
Journal:  J Immunol       Date:  2015-08-31       Impact factor: 5.422

6.  [18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation.

Authors:  Delphine L Chen; Timothy J Bedient; James Kozlowski; Daniel B Rosenbluth; Warren Isakow; Thomas W Ferkol; Betsy Thomas; Mark A Mintun; Daniel P Schuster; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2009-07-02       Impact factor: 21.405

7.  Combination use of immune complexes and a Ca2(+) channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells.

Authors:  T Abe; I Fuse; M Narita; M Takahashi; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

8.  Interleukin-12p40 modulates human metapneumovirus-induced pulmonary disease in an acute mouse model of infection.

Authors:  Krishnendu Chakraborty; Zehua Zhou; Nobuko Wakamatsu; Antonieta Guerrero-Plata
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

9.  Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis.

Authors:  Avraham Beigelman; Cassandra L Mikols; Sean P Gunsten; Carolyn L Cannon; Steven L Brody; Michael J Walter
Journal:  Respir Res       Date:  2010-06-30

10.  Accelerated wound healing phenotype in Interleukin 12/23 deficient mice.

Authors:  Marie At Matias; Jodi M Saunus; Saso Ivanovski; Laurence J Walsh; Camile S Farah
Journal:  J Inflamm (Lond)       Date:  2011-12-20       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.